SCIEX Receive Science and Technology Award at HUPO 2017
News Sep 21, 2017
SCIEX, has announced that two SCIEX researchers have received the Science and Technology Award at the 16th Human Proteome Organization World Congress, HUPO2017, which was recently held in Dublin, Ireland. The award was presented to Stephen Tate and Ron Bonner from SCIEX, for their significant role in the development of SWATH® Acquisition technology commonly referred to as data-independent-acquisition (DIA). “This significant innovation in the proteomics field has had wide acceptance and provides a springboard for proteomics technology to impact the field of translational clinical proteomics,” states the HUPO organization. “The HUPO members applaud the efforts of Dr. Bonner and Dr Tate for the award in Science and Technology.”
During the event, SCIEX featured its advanced quadrupole time-of-flight mass spectrometry proteomics platforms, which enable the SWATH acquisition workflow and allows quantification of thousands of proteins across large sample sets with greater accuracy and reproducibility than ever before. The challenge of unlocking the proteome requires innovative tools and technology to detect and quantify more proteins for deeper insights. The SCIEX TripleTOF® 6600 System in combination with SWATH Acquisition delivers the combination of comprehensive coverage with low coefficients of variation previously achievable only by targeted techniques - providing comprehensive high quality quantitative datasets.
SCIEX SWATH Acquisition technology, now celebrating five years since introduced, enables the quantification of thousands of proteins across large sample sets with an unprecedented level of data completeness, quantitative accuracy and reproducibility. SWATH Acquisition allows for comprehensive quantification, which is critical in biomarker or systems biology research. This new technology has transformed proteomics experiments, allowing all data to be captured across very large sample cohorts and now in combination with microflow chromatography, enabling industrialised proteomics. Recently, three primary research articles1 were published, demonstrating the reproducibility of quantitative proteomics data by multiple labs using SWATH Acquisition, discussing how to deal with the false positive inflation issue2, and focusing on post-translational modifications and the inference of peptidoforms algorithm3, respectively.
SCIEX presented work on advancing proteomics research at HUPO2017, including a talk by Stephen Tate and Ron Bonner on the development of the SWATH workflow during the congress award session. SCIEX also hosted a seminar entitled “Biomarkers in Ovarian Cancer from SWATH® maps of clinical samples”. The seminar – which was filled to capacity – gave new insights into use of SCIEX solutions for precision medicine research and quantitative proteomics. The invited speaker was Robert Graham Ph.D., Sr Lecturer in Clinical Proteomics, Deputy Director Stoller Biomarker Discovery Centre, University of Manchester.
Just prior to the conference, SCIEX hosted a VIP round-table discussion focused on the advancement of precision medicine and the major challenges researchers are faced with. Participating in the in-depth discussion were internationally renowned researchers:
- Professor Anthony Whetton, Director, Stoller Biomarker Discovery Centre, University of Manchester, UK
- Professor Jennifer Van Eyk, Director, Advanced Clinical Biosystems Institute, Cedars-Sinai Medical Centre, Los Angeles, USA
- Professor Phil Robinson, Co-leader, PROCAN, Children’s Medical Research Institute, Sydney, Australia
- Professor Thomas Conrads, Chief Scientific Officer, Women’s Health Integrated Research Center, Inova Health System, Falls Church, USA
- Associate Professor Mark Malloy, Department of Chemistry & Biomeolecular Sciences, Macquarie University, Sydney, Australia
“We are pleased to have organised and facilitated so many important discussions with researchers, some from the leading edge of precision medicine to those who are interested in high-performance solutions for quantitative proteome analysis at HUPO2017,” said Mark Cafazzo, Director of Academic and Applied Markets at SCIEX. “We are also happy to celebrate the fifth anniversary of our unique SWATH Acquisition technology and we believe that our cutting-edge technologies and applications will continue to help customers examine the proteome more completely, addressing diverse needs across the research pipeline. We are committed to advancing the leading edge of biomarker research in order to unlock knowledge that will positively impact more people’s lives.”
This article has been republished from materials provided by SCIEX. Note: material may have been edited for length and content. For further information, please contact the cited source.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.